Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ black women at risk for cervical cancer

Psychosomatic Medicine

Volumn 60, Issue 6, 1998, Pages 714-722

  Byrnes, Deidre M ^a   Antoni, Michael H ^a,c   Goodkin, Karl ^a,b,c   Efantis Potter, Jonell ^c   Asthana, Deshratn ^b   Simon, Trudi ^c   Munajj, Josefina ^c   Ironson, Gail ^a,c   Fletcher, Mary Ann ^a,b  

^a University of Miami   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

African American; HIV 1; Human papillomavirus; Natural killer cell cytotoxicity; Pessimism

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEGRO; PATIENT ATTITUDE; PRIORITY JOURNAL; STRESS; SUPPRESSOR CELL; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0031786112     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199811000-00009     Document Type: Article

References (75)

1. Centers for Disease Control: HIV/AIDS surveillance report: US HIV and AIDS cases reported through December 1996 (Vol. 8, No. 2). Atlanta, GA, 1996
2. Laga M, Icenogle JP, Marsella R, et al: Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 50:45-48, 1992
3. Maiman M, Tarricone N, Vieira J, et al: Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol 78:84-88, 1991
4. Petry KU, Kochel H, Bode U, et al: Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol 60:30-34, 1996
5. Schafer A, Friedmann W, Mielke M, et al: The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 164:593-599, 1991
6. Spinillo A, Tenti P, Zappatore R, et al: Prevalence, diagnosis, and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol Reprod Biol 43:235-241, 1992
7. Sun X, Ellerbrock TV, Lungu O, et al: Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 85:680-686, 1995
8. Williams AB, Darragh TM, Vranizan K, et al: Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 83:205-211, 1994
9. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep (MMWR) 41:1-19, 1992
10. Brisson J, Morin C, Fortier M, et al: Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions. Am J Epidemiol 140:700-710, 1994
11. Chan MKM, Lau LM, Tsui Y, et al: Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervix - detection by polymerase chain reaction method on cervical scrapes. Gynecol Oncol 60:217-223, 1996
12. Katase K, Teshima H, Hirai Y, et al: Natural history of cervical human papillomavirus lesions. Intervirology 38:192-194, 1995
13. Liaw K, Hsing AW, Chen C, et al: Human papillomavirus and cervical neoplasia: A case control study in Taiwan. Int J Cancer 62:565-571, 1995
14. Olsen A, Gjoen K, Sauer T, et al: Human papillomavirus and cervical intraepithelial neoplasia grade II-III: A population-based case-control study. Int J Cancer 61:312-315, 1995
15. Remmink AJ, Walboomers JMM, Heimerhorst TJM, et al: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 61:306-311, 1995
16. Wang PD, Lin RS: Risk factors for cervical intraepithelial neoplasia in Taiwan. Gynecol Oncol 62:10-18, 1996
17. Halpert R, Fruchter RG, Sedlis A, et al: Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 68:251-258, 1986
18. Penn I: Cancers of the anogenital region in renal transplant recipients. Cancer 58:611-616, 1986
19. Katz RL, Veanattukalathil S, Weiss KM: Human papillomavirus infection and neoplasia of the cervix and anogenital region in women with Hodgkin's disease. Acta Cytol 31:845-854, 1987
20. Barton SE, Hollingworth A, Maddox PH, et al: Possible cofactors in the etiology of cervical intraepithelial neoplasia. An immunopathic study. J Reprod Med 34:613-616, 1989
21. Castello G, Esposito G, Stellato G, et al: Immunological abnormalities in patients with cervical carcinoma. Oncology 25:61-64, 1985
22. Nair BS, Pillai R: Oncogenesis of squamous carcinoma of the uterine cervix. Int J Gynecol Pathol 11:47-57, 1992
23. Bagot M, Charue D, Cerni C, et al: Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigens. Res Virol 147:301-11, 1996
24. Edwards RP, Kuykendall K, Crowley-Nowick P, et al: T lymphocytes infiltrating advanced grades of cervical neoplasia CD8-positive cells are recruited to invasion. Cancer 76:1411-1415, 1995
25. Widmann FK: An Introduction to Clinical Immunology. Philadelphia, FA Davis, 1989, 120-121
26. Oldstone MBA: HIV versus cytotoxic T lymphocytes - the war being lost. N Engl J Med 337:1306-1308, 1997
27. Musey L, Hughes J, Schacker T, et al: Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type I infection. N Engl J Med 337: 1267-1274, 1997
28. Tay SK, Jenkins D, Singer A: Natural killer cells in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol 94:901-906, 1989
29. Satam MN, Suraiya JN, Nadkarni JJ: Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients. Cancer Immunol Immunother 23:56-59, 1986
30. Seltzer V, Doyle A, Kadish AS: Natural cytotoxicity in malignant and premalignant cervical neoplasia and enhancement of cytotoxicity with interferon. Gynecol Oncol 15:340-349, 1983
31. Clerici M, Merola M, Ferrario E, et al: Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection. J Natl Cancer Inst 89:245-250, 1997
32. Scheier MF, Bridges MW: Person variables and health: Personality predispositions and acute psychological states as shared determinants for disease. Psychosom Med 57:255-268, 1995
33. Irwin M, Patterson T, Smith TL, et al: Reduction of immune function in life stress and depression. Biol Psychiatry 27:22-30, 1990
34. Ironson G, Wynings C, Schneiderman N, et al: Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med 59:128-141, 1997
35. Kemeny ME, Cohen F, Zegans LS, et al: Psychological and immunological predictors of genital herpes recurrence. Psychosom Med 51:195-208, 1989
36. Glaser R, Kiecolt-Glaser JK, Speicher CE, et al: Stress, loneliness, and changes in herpesvirus latency. J Behav Med 8:249-260, 1985
37. McKinnon W, Weisse CS, Reynolds CP, et al: Chronic stress, leukocyte subpopulations, and humoral response to latent viruses. Health Psychol 8:389-402, 1989
38. Kamen-Siegel L, Rodin J, Seligman MEP, et al: Explanatory style and cell-mediated immunity in elderly men and women. Health Psychol 10:229-235, 1991
39. Lin EH, Peterson C: Pessimistic explanatory style and response to illness. Behav Res Ther 28:243-248, 1990
40. Peterson C: Explanatory style as a risk factor for illness. Cognitive Ther Res 12:119-132, 1988
41. Schulz R, Bookwala J, Kapp JE, et al: Pessimism, age, and cancer mortality. Psychol Aging 11:304-309, 1996
42. Reed GM, Kemeny ME, Taylor SE, et al: "Realistic acceptance" as a predictor of decreased survival time in gay men with AIDS. Health Psychol 13:299-307, 1994
43. Antoni MH, Goodkin K: Host moderator variables in the promotion of cervical neoplasia. I. Personality facets. J Psychosom Res 32:327-338, 1988
44. Antoni MH, Goodkin K: Host moderator variables in the promotion of cervical neoplasia. II. Dimensions of life stress. J Psychosom Res 33:457-467, 1989
45. Goodkin K, Antoni MH, Blaney PH: Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J Psychosom Res 30:67-76, 1986
46. Ley C, Bauer HM, Reingold A, et al: Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83:997-1003, 1991
47. Graham NM, Zeger SL, Park LP et al: The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 326:1037-1042, 1992
48. Brown GW, Craig TK, Harris TO: Depression: Distress or disease? Some epidemiological considerations. Br J Psychiatry 147:612-622, 1985
49. Greenwood D, Szapocznik J, Mcintosh S, et al: African-American women, their families, and HIV/AIDS. Health Psychology Through the Lifespan, Washington, DC, American Psychological Association, 1996, 349-359
50. Malow RM, Jager KB, Ireland SJ, et al: HIV infection and risky sexual behaviors among women in treatment for noninjection drug dependence. Psychiatr Serv 47:1197-1199, 1996
51. Smith EM: Ethnic minorities: Life stress, social support, and mental health issues. Counseling Psychol 13:537-579, 1985
52. Sarason IG, Johnson JH, Siegel JM: Assessing the impact of life change: Development of the Life Experiences Survey. J Consult Clin Psychol 46:932-946, 1978
53. Millon T, Green C, Meagher R: Millon Behavioral Health Inventory Manual. Minneapolis, MN, National Computer Services, 1982
54. Goodkin K, Antoni MH, Helder L, et al: Psychoneuroimmunological aspects of disease progression among women with human papillomavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Int J Psychiatry Med 23:119-148, 1993
55. Kelly JA, St. Lawrence JS, Hood HV, et al: Behavioral interventions to reduce AIDS risk activities. J Consult Clin Psychol 57:60-67, 1989
56. Benedet JL: Instrumentation and technique of colposcopy. In Wright VC, Lickrish GM (eds). Basic and Advanced Colposcopy: A Practical Handbook for Diagnosis and Treatment. Houston, Biomedical Communications, 1989, 17-26
57. Reid RI, Lörincz AT: New generation of human papillomavirus tests. In Rubin SC, Hoskins WJ (eds), Cervical Cancer and Preinvasive Neoplasia. Philadelphia, Lippincott-Raven, 1996, 27-47
58. Hording U, Junge J, Rygaard C, et al: Management of low-grade CIN: Follow-up or treatment? Eur J Obstet Gynecol Reprod Biol 62:49-52, 1995
59. Fletcher MA, Baron GC, Ashman MR, et al: Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol 5:69-81, 1987
60. Patarca R, Fletcher MA, Podack ER: Cytolytic cell function. In Rose NR, de Macario EC, Folds JD, et al (eds). Manual of Clinical Laboratory Immunology. Washington, DC, American Society for Microbiology, 1997, 296-303
61. West-Edwards CAC, Byrnes-Pereira D, Greenwood DU, et al: Stress management and relaxation training intervention for HIV+ African American women: Preliminary findings. Poster presented at the American Psychological Association, August 1997
62. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111, 1993
63. Carver CS, Scheier MF: Origins and functions of positive and negative affect: A control-process view. Psychol Rev 97:19-35, 1990
64. Ritchie JC, Nemeroff CB: Stress, the hypothalamic-pituitary-adrenal axis, and depression. In McCubbin JA, Kaufmann PG, Nemeroff CB (eds), Stress, Neuropeptides, and Systemic Disease. San Diego, CA, Academic Press, 1991, 181-197
65. Fletcher MA, Ironson G, Goodkin K, et al: Stress and immune function in HIV-1 disease. In Hubbard IR, Workman EA (eds), Handbook of Stress Medicine. Boca Raton, FL. CRC Press, 1997, 229-242
66. Levy S, Herberman R, Lippman M, et al: Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5:348-352, 1987
67. Felten DL, Felten SY, Carlson SL, et al: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135:755-765, 1985
68. Schneiderman N, Antoni MH, Ironson G: Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psychol AIDS Exchange 22:1-8, 1997
69. Irwin M, Mascovich A, Gillin J, et al: Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom Med 56:493-497, 1994
70. Moldofsky H: Sleep and the immune system. Int J Immunopharmacol 17:649-654, 1995
71. Chandra RK: Nutrition and immunoregulation: Significance for host resistance to tumors and infectious diseases in humans and rodents. J Nutr 122:754-757, 1992
72. Delafuente JC: Nutrients and immune responses. Rheum Dis Clin North Am 17:203-212, 1991
73. Ioannidis JP, Cappelleri JC, Lau J, et al: Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: A mathematical model. AIDS 10:255-262, 1996
74. Lafueillade A, Poggi C, Pellegrino P, et al: Serum HIV-1 RNA load to predict CD4+ T-cell depletion in asymptomatic patients. Infection 24:245-247, 1996
75. Mellors JW, Rinaldo CR, Gupta P, et al: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170, 1996